Hudson Bay Capital Management LP Adagene Inc. Transaction History

Hudson Bay Capital Management LP

  • $21.9 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$1.24 - $2.09 $129,788 - $218,756
-104,668 Reduced 67.67%
50,000 $64,000
Q2 2022

Aug 12, 2022
SELL
$1.99 - $3.85 $146,865 - $284,137
-73,802 Reduced 32.3%
154,668 $311,000
Q1 2022

May 16, 2022
SELL
$3.5 - $8.79 $360,755 - $906,011
-103,073 Reduced 31.09%
228,470 $816,000
Q1 2021

May 14, 2021
BUY
$17.0 - $29.99 $5.64 Million - $9.94 Million
331,543 New
331,543 $5.95 Million

Others Institutions Holding ADAG

# of Institutions
14
Shares Held
13.6M
Call Options Held
0
Put Options Held
0
View Full List

About Adagene Inc.

ADAG Quotes by TradingView
  • Ticker ADAG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,423,200
  • Market Cap $74.7M
  • Description
  • Adagene Inc., a clinical stage biopharmaceutical company, engages in the research, development, and production of monoclonal antibody drugs for cancers. The company's product candidates include ADG106, a human ligand-blocking agonistic anti-CD137 monoclonal antibodies (mAbs) that is in Phase 1b/2 clinical trials for the treatment advanced solid ...
More about ADAG
Track This Portfolio

Track Hudson Bay Capital Management LP Portfolio

Follow Hudson Bay Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hudson Bay Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Hudson Bay Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email